{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:27:56Z","timestamp":1773736076910,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["66777"],"award-info":[{"award-number":["66777"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["65061"],"award-info":[{"award-number":["65061"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11033-025-10786-8","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:04:03Z","timestamp":1751537043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interleukin-17 and interleukin-23 cytokine profiles in palindromic rheumatism: potential therapeutic targets and prognostic biomarkers for disease progression to rheumatoid arthritis"],"prefix":"10.1007","volume":"52","author":[{"given":"Kamran","family":"Javidi-Aghdam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Akbarzadeh-Khiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arezoo","family":"Ghasembaglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Rahbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida Malek","family":"Mahdavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Jafarpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8997-2003","authenticated-orcid":false,"given":"Azam","family":"Safary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-6967","authenticated-orcid":false,"given":"Alireza","family":"Khabbazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"issue":"11","key":"10786_CR1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41584-019-0308-5","volume":"15","author":"K Mankia","year":"2019","unstructured":"Mankia K, Emery P (2019) Palindromic rheumatism as part of the rheumatoid arthritis continuum. Nat Rev Rheumatol 15(11):687\u2013695","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10786_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.2008.00626.x","volume":"223","author":"M Feldmann","year":"2008","unstructured":"Feldmann M, Maini SRN (2008) Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol Rev 223(1):7\u201319","journal-title":"Immunol Rev"},{"issue":"1","key":"10786_CR3","first-page":"41","volume":"27","author":"L Gonzalez-Lopez","year":"2000","unstructured":"Gonzalez-Lopez L, Gamez-Nava JI, Jhangri G et al (2000) Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J Rheumatol 27(1):41\u201346","journal-title":"J Rheumatol"},{"issue":"1","key":"10786_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.berh.2017.09.014","volume":"31","author":"K Mankia","year":"2017","unstructured":"Mankia K, Emery P (2017) What can palindromic rheumatism tell us? Best Pract Res Clin Rheumatol 31(1):90\u201398","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10786_CR5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/1744666X.2021.1899811","volume":"17","author":"R Sanmart\u00ed","year":"2021","unstructured":"Sanmart\u00ed R, Haro I, Ca\u00f1ete JD (2021) Palindromic rheumatism: a unique and enigmatic entity with a complex relationship with rheumatoid arthritis. Expert Rev Clin Immunol 17(4):375\u2013384","journal-title":"Expert Rev Clin Immunol"},{"key":"10786_CR6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10067-014-2569-3","volume":"33","author":"Y Emad","year":"2014","unstructured":"Emad Y, Anbar A, Abo-Elyoun I et al (2014) In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin Rheumatol 33:791\u2013797","journal-title":"Clin Rheumatol"},{"key":"10786_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02982543","volume":"74","author":"JJ Oppenheim","year":"2001","unstructured":"Oppenheim JJ (2001) Cytokines: past, present, and future. Int J Hematol 74:3\u20138","journal-title":"Int J Hematol"},{"key":"10786_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09629350120054518","volume":"10","author":"F Chung","year":"2001","unstructured":"Chung F (2001) Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-\u03b3. Mediators Inflamm 10:51\u201359","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10786_CR9","first-page":"695","volume":"47","author":"J-M Cavaillon","year":"2001","unstructured":"Cavaillon J-M (2001) Pro-versus anti-inflammatory cytokines: myth or reality. Cell Mol Biology-Paris-Wegmann- 47(4):695\u2013702","journal-title":"Cell Mol Biology-Paris-Wegmann"},{"issue":"1","key":"10786_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/2277-9175.133249","volume":"3","author":"R Farahani","year":"2014","unstructured":"Farahani R, Sherkat R, Hakemi MG et al (2014) Cytokines (interleukin-9, IL-17, IL-22, IL-25 and IL-33) and asthma. Adv Biomed Res 3(1):127","journal-title":"Adv Biomed Res"},{"issue":"1","key":"10786_CR11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","volume":"14","author":"M Feldmann","year":"1996","unstructured":"Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14(1):397\u2013440","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"10786_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","volume":"12","author":"IB McInnes","year":"2016","unstructured":"McInnes IB, Buckley CD, Isaacs JD (2016) Cytokines in rheumatoid arthritis\u2014shaping the immunological landscape. Nat Rev Rheumatol 12(1):63\u201368","journal-title":"Nat Rev Rheumatol"},{"key":"10786_CR13","doi-asserted-by":"crossref","first-page":"637829","DOI":"10.3389\/fimmu.2021.637829","volume":"12","author":"C Schinocca","year":"2021","unstructured":"Schinocca C, Rizzo C, Fasano S et al (2021) Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview. Front Immunol 12:637829","journal-title":"Front Immunol"},{"issue":"1","key":"10786_CR14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12016-020-08823-4","volume":"60","author":"H Li","year":"2021","unstructured":"Li H, Tsokos GC (2021) IL-23\/IL-17 Axis in inflammatory rheumatic diseases. Clin Rev Allergy Immunol 60(1):31\u201345","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10786_CR15","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/ni.3742","volume":"18","author":"M Veldhoen","year":"2017","unstructured":"Veldhoen M (2017) Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 18(6):612\u2013621","journal-title":"Nat Immunol"},{"issue":"4","key":"10786_CR16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.immuni.2004.08.018","volume":"21","author":"JK Kolls","year":"2004","unstructured":"Kolls JK, Lind\u00e9n A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467\u2013476","journal-title":"Immunity"},{"issue":"1","key":"10786_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/14728222.2013.843669","volume":"18","author":"J-W Yan","year":"2014","unstructured":"Yan J-W, Wang Y-J, Peng W-J et al (2014) Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases. Expert Opin Ther Targets 18(1):29\u201341","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"10786_CR18","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5114\/pdia.2014.40954","volume":"31","author":"AG Shabgah","year":"2014","unstructured":"Shabgah AG, Fattahi E, Shahneh FZ (2014) Interleukin-17 in human inflammatory diseases. Adv Dermatology Allergology\/Post\u0119py Dermatologii I Alergologii 31(4):256\u2013261","journal-title":"Adv Dermatology Allergology\/Post\u0119py Dermatologii I Alergologii"},{"issue":"6","key":"10786_CR19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1902\/jop.2007.060392","volume":"78","author":"JM Kramer","year":"2007","unstructured":"Kramer JM, Gaffen SL (2007) Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 78(6):1083\u20131093","journal-title":"J Periodontol"},{"issue":"4","key":"10786_CR20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/rheumatology\/keaa629","volume":"60","author":"D Wu","year":"2021","unstructured":"Wu D, Wong P, Lam SH et al (2021) The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study. Rheumatology 60(4):1963\u20131973","journal-title":"Rheumatology"},{"issue":"1","key":"10786_CR21","first-page":"277","volume":"16","author":"R Zhao","year":"2023","unstructured":"Zhao R, Zhang Y-w, Yao J-y et al (2023) Genetic association between interleukin-17 and susceptibility to rheumatoid arthritis. BMC Med Genet 16(1):277 2023\/11\/06","journal-title":"BMC Med Genet"},{"issue":"2","key":"10786_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2015.01.003","volume":"75","author":"C Konya","year":"2015","unstructured":"Konya C, Paz Z, Apostolidis SA, Tsokos GC (2015) Update on the role of Interleukin 17 in rheumatologic autoimmune diseases. Cytokine 75(2):207\u2013215","journal-title":"Cytokine"},{"issue":"7","key":"10786_CR23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/07853890.2011.577093","volume":"43","author":"E Duvallet","year":"2011","unstructured":"Duvallet E, Semerano L, Assier E et al (2011) Interleukin-23: a key cytokine in inflammatory diseases. Ann Med 43(7):503\u2013511","journal-title":"Ann Med"},{"issue":"4","key":"10786_CR24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.biocel.2008.04.027","volume":"41","author":"ZY Tan","year":"2009","unstructured":"Tan ZY, Bealgey KW, Fang Y et al (2009) Interleukin-23: immunological roles and clinical implications. Int J Biochem Cell Biol 41(4):733\u2013735","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10786_CR25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.12840","volume":"294","author":"C Bridgewood","year":"2020","unstructured":"Bridgewood C, Sharif K, Sherlock J et al (2020) Interleukin-23 pathway at the enthesis: the emerging story of enthesitis in spondyloarthropathy. Immunol Rev 294(1):27\u201347","journal-title":"Immunol Rev"},{"issue":"1","key":"10786_CR26","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-065X.2008.00705.x","volume":"226","author":"PP Ahern","year":"2008","unstructured":"Ahern PP, Izcue A, Maloy KJ, Powrie F (2008) The interleukin-23 axis in intestinal inflammation. Immunol Rev 226(1):147\u2013159","journal-title":"Immunol Rev"},{"issue":"7","key":"10786_CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ibd.20894","volume":"15","author":"C Abraham","year":"2009","unstructured":"Abraham C, Cho J (2009) Interleukin-23\/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 15(7):1090\u20131100","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10786_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0002-9343(92)90177-D","volume":"93","author":"P-A Guerne","year":"1992","unstructured":"Guerne P-A, Weisman MH (1992) Palindromic rheumatism: part of or apart from the spectrum of rheumatoid arthritis. Am J Med 93(4):451\u2013460","journal-title":"Am J Med"},{"issue":"9","key":"10786_CR29","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10786_CR30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.reumae.2019.01.005","volume":"17","author":"A Khabbazi","year":"2021","unstructured":"Khabbazi A, Mirza-Aghazadeh-Attari M, Goli MT et al (2021) Is palindromic rheumatism a Pre-rheumatoid arthritis condition? Low incidence of rheumatoid arthritis in palindromic rheumatism patients treated with tight control strategy. Reumatolog\u00eda Cl\u00ednica (English Edition) 17(1):7\u201311","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"issue":"1","key":"10786_CR31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2018t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10786_CR32","first-page":"333","volume":"42","author":"A Farah Izati","year":"2020","unstructured":"Farah Izati A, Wong KK, Che Maraina CH (2020) IL-23\/IL-17 axis in the pathogenesis and treatment of systemic lupus erythematosus and rheumatoid arthritis. Malays J Pathol 42(3):333\u2013347","journal-title":"Malays J Pathol"},{"issue":"2","key":"10786_CR33","first-page":"85","volume":"20","author":"EM Abu Al Fadl","year":"2013","unstructured":"Abu Al Fadl EM, Fattouh M, Allam AA (2013) High IL-23 level is a marker of disease activity in rheumatoid arthritis. Egypt J Immunol 20(2):85\u201392","journal-title":"Egypt J Immunol"},{"issue":"7","key":"10786_CR34","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","volume":"7","author":"WJ van Venrooij","year":"2011","unstructured":"van Venrooij WJ, van Beers JJ, Pruijn GJ (2011) Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol 7(7):391\u2013398","journal-title":"Nat Rev Rheumatol"},{"key":"10786_CR35","doi-asserted-by":"crossref","unstructured":"Mudigonda P, Mudigonda T, Feneran AN, et al. Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J. 2012;18(10).","DOI":"10.5070\/D33N39N8XM"},{"issue":"2","key":"10786_CR36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1378\/chest.118.2.503","volume":"118","author":"CA Dinarello","year":"2000","unstructured":"Dinarello CA (2000) Proinflammatory cytokines. Chest 118(2):503\u2013508","journal-title":"Chest"},{"issue":"12","key":"10786_CR37","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","volume":"20","author":"X Li","year":"2019","unstructured":"Li X, Bechara R, Zhao J et al (2019) IL-17 receptor-based signaling and implications for disease. Nat Immunol 20(12):1594\u20131602","journal-title":"Nat Immunol"},{"issue":"8","key":"10786_CR38","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.3899\/jrheum.131545","volume":"41","author":"S Cabrera-Villalba","year":"2014","unstructured":"Cabrera-Villalba S, Ramirez J, Salvador G et al (2014) Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated protein antibody status. J Rheumatol 41(8):1650\u20131655","journal-title":"J Rheumatol"},{"key":"10786_CR39","doi-asserted-by":"crossref","first-page":"155837","DOI":"10.1016\/j.cyto.2022.155837","volume":"153","author":"S Misra","year":"2022","unstructured":"Misra S, Mondal S, Chatterjee S et al (2022) Interleukin-17 as a predictor of subclinical synovitis in the remission state of rheumatoid arthritis. Cytokine 153:155837","journal-title":"Cytokine"},{"key":"10786_CR40","doi-asserted-by":"crossref","unstructured":"Chen J-Q, Szodoray P, Zeher M. Toll-Like Receptor Pathways in Autoimmune Diseases. Clin Rev Allergy Immunol. 2016 2016\/02\/01;50(1):1\u201317.","DOI":"10.1007\/s12016-015-8473-z"},{"issue":"9","key":"10786_CR41","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10067-011-1737-y","volume":"30","author":"SA Metawi","year":"2011","unstructured":"Metawi SA, Abbas D, Kamal MM, Ibrahim MK (2011) Serum and synovial fluid levels of interleukin-17 in correlation with disease activity in patients with RA. Clin Rheumatol 30(9):1201\u20131207 2011\/09\/01;","journal-title":"Clin Rheumatol"},{"issue":"10155","key":"10786_CR42","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0140-6736(18)32167-6","volume":"392","author":"RF van Vollenhoven","year":"2018","unstructured":"van Vollenhoven RF, Hahn BH, Tsokos GC et al (2018) Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study. Lancet 392(10155):1330\u20131339","journal-title":"Lancet"},{"issue":"10","key":"10786_CR43","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s10067-019-04595-1","volume":"38","author":"Y Huang","year":"2019","unstructured":"Huang Y, Fan Y, Liu Y et al (2019) Efficacy and safety of Secukinumab in active rheumatoid arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis of phase III randomized controlled trials. Clin Rheumatol 38(10):2765\u20132776","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10786_CR44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/rheumatology\/kel159","volume":"46","author":"H-R Kim","year":"2006","unstructured":"Kim H-R, Cho M-L, Kim K-W et al (2006) Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-\u03baB- and p38 MAPK-dependent signalling pathways. Rheumatology 46(1):57\u201364","journal-title":"Rheumatology"},{"key":"10786_CR45","doi-asserted-by":"crossref","unstructured":"Mrabet D, Laadhar L, Sahli H, et al. Synovial fluid and serum levels of IL-17, IL-23, and CCL-20 in rheumatoid arthritis and psoriatic arthritis: a Tunisian cross-sectional study. Rheumatol Int. 2013 2013\/01\/01;33(1):265\u2013266.","DOI":"10.1007\/s00296-011-2231-1"},{"issue":"01","key":"10786_CR46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"2011\/02","author":"Y Mei","year":"2011","unstructured":"Mei Y, Pan F, Gao J et al (2011) Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol 2011\/02(01):269\u2013273","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10786_CR47","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q et al (2009) Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 29(11):1343\u20131347 2009\/09\/01;","journal-title":"Rheumatol Int"},{"issue":"5","key":"10786_CR48","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1177\/0300060513509130","volume":"42","author":"J Du","year":"2014","unstructured":"Du J, Li Z, Shi J, Bi L (2014) Associations between serum interleukin-23 levels and clinical characteristics in patients with systemic lupus erythematosus. J Int Med Res 42(5):1123\u20131130","journal-title":"J Int Med Res"},{"key":"10786_CR49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-94-024-0921-5_8","volume":"941","author":"I Welsby","year":"2016","unstructured":"Welsby I, Goriely S (2016) Regulation of Interleukin-23 expression in health and disease. Adv Exp Med Biol 941:167\u2013189","journal-title":"Adv Exp Med Biol"},{"key":"10786_CR50","doi-asserted-by":"crossref","unstructured":"Welsby I, Goriely S. Regulation of interleukin-23 expression in health and disease. Regulation of Cytokine Gene Expression in Immunity and Diseases. 2016:167\u2013189.","DOI":"10.1007\/978-94-024-0921-5_8"},{"issue":"1","key":"10786_CR51","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-065X.2008.00700.x","volume":"226","author":"L Lyakh","year":"2008","unstructured":"Lyakh L, Trinchieri G, Provezza L et al (2008) Regulation of interleukin-12\/interleukin\u201023 production and the T\u2010helper 17 response in humans. Immunol Rev 226(1):112\u2013131","journal-title":"Immunol Rev"},{"key":"10786_CR52","doi-asserted-by":"crossref","first-page":"657983","DOI":"10.3389\/fmed.2021.657983","volume":"8","author":"R Sanmart\u00ed","year":"2021","unstructured":"Sanmart\u00ed R, Frade-Sosa B, Morl\u00e0 R et al (2021) Palindromic rheumatism: just a pre-rheumatoid stage or something else? Front Med 8:657983","journal-title":"Front Med"},{"key":"10786_CR53","doi-asserted-by":"crossref","first-page":"102175","DOI":"10.1016\/j.genrep.2025.102175","volume":"39","author":"K Javidi-Aghdam","year":"2025","unstructured":"Javidi-Aghdam K, Akbarzadeh-Khiavi M, Parvizpour S et al (2025) Upregulation of TNF-\u03b1 and IL-6 in palindromic rheumatism: A biomarker link to rheumatoid arthritis progression and therapeutic implications. Gene Rep 39:102175","journal-title":"Gene Rep"},{"issue":"8","key":"10786_CR54","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/art.22755","volume":"56","author":"JD Ca\u00f1ete","year":"2007","unstructured":"Ca\u00f1ete JD, Arostegui JI, Queir\u00f3 R et al (2007) An unexpectedly high frequency of MEFV mutations in patients with anti\u2013citrullinated protein antibody\u2013negative palindromic rheumatism. Arthritis Rheum 56(8):2784\u20132788","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10786_CR55","doi-asserted-by":"crossref","first-page":"e15280","DOI":"10.1111\/1756-185X.15280","volume":"27","author":"S Shahmohammadi-Farid","year":"2024","unstructured":"Shahmohammadi-Farid S, Asgharvand\u2010Hajeb A, Javidi\u2010Aghdam K et al (2024) Frequency of HLA\u2010DRB1 alleles in palindromic rheumatism in the Azeri population. Int J Rheum Dis 27(8):e15280","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10786_CR56","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.42614","volume":"75","author":"C Zheng","year":"2023","unstructured":"Zheng C, Wang F, Sun Y et al (2023) Identification of distinct genetic profiles of palindromic rheumatism using whole-exome sequencing. Arthritis Rheumatol 75(11):1947\u20131957","journal-title":"Arthritis Rheumatol"},{"key":"10786_CR57","doi-asserted-by":"crossref","unstructured":"Gamal SM, Eleishi HH, Moghazy A, et al. Effect of education on disease activity and functional status in rheumatoid arthritis patients. Egypt Rheumatol. 2021 2021\/01\/01\/;43(1):7\u201311.","DOI":"10.1016\/j.ejr.2020.12.001"},{"key":"10786_CR58","doi-asserted-by":"crossref","unstructured":"Dey M, Busby A, Elwell H, et al. Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review. RMD Open. 2022 Apr;8(1).","DOI":"10.1136\/rmdopen-2021-002058"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-10786-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-10786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T04:24:32Z","timestamp":1766895872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-10786-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10786"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-10786-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"assertion":[{"value":"22 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (IR.TBZMED.REC.1399.205). The written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent was obtained from all patients to publish their clinical information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"672"}}